Aberrant carbohydration by related glycosyl-
transferases plays an important role in the progression of
cancer. This study focused on the ablity of β-1,3-N-acetyl-glucosaminyltransferase-8 (β3GnT8) to regulate MMP-2 expression through regulation of the CD147 signal transduction pathway in
cancer cells. β3GnT8 catalyzes and then extends a
polylactosamine chain specifically on β1-6-branched tetraantennary N-
glycans. CD147 is a major carrier of β1-6-branched
polylactosamine sugars on
tumor cells, and the high glycoform of CD147 (HG-CD147) induces
matrix metalloproteinase (
MMP) production. In the present study, we analyzed β3GnT8
mRNA expression in 6
cancer cell lines (MCF-7, M231, LN229, U87, SGC-7901 and U251). We found that β3GnT8 expression in the LN229, SGC-7901 and U251 cell lines was higher than that in the other cell lines. Therefore, we established β3GnT8-knockdown cell lines derived from the LN229 and SGC-7901 cell lines to examine the level of
polylactosamine and CD147 N-glycosylation. In addition,
tunicamycin is widely used as an inhibitor of N-linked glycosylation. Hence, various concentrations of
tunicamycin were used to treat the cells in order to study its influence on CD147 N-glycosylation and MMP-2 expression. In conclusion, we found that β3GnT8 regulated the level of N-
glycans on CD147 and that N-glycosylation of CD147 has an important effect on MMP-2 expression. Our findings suggest that β3GnT8 affects the signal transduction pathway of MMP-2 by altering the N-
glycan structure of CD147.